Active	Status	Sponsor type	Region	Phase	Filter
5 Active 14 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ruggenenti, Piero
MONET, NCT04893096: MOR202 for Refractory MN	Active, not recruiting	2	10	Europe	MOR202, FELZARTAMAB	Mario Negri Institute for Pharmacological Research, MorphoSys AG	Membranous Nephropathy	02/25	02/25
ORION, NCT05050214: Obinutuzumab in Primary MN	Active, not recruiting	2	20	Europe	Obinutuzumab, GAZYVA, GAZYVARO	Mario Negri Institute for Pharmacological Research, Roche Pharma AG	Membranous Nephropathy	04/25	04/25
NCT02012153: Mesenchymal Stromal Cells in Kidney Transplant Recipients	Terminated	1	3	Europe	Mesenchymal Stromal Cells	Mario Negri Institute for Pharmacological Research, A.O. Ospedale Papa Giovanni XXIII	Kidney Transplant Rejection	05/23	05/23
ADPKD648, NCT06193616: Outcome of ADPKD With Octreotide LAR	Recruiting	N/A	70	Europe	Octreotide, Octreotide LAR	Mario Negri Institute for Pharmacological Research	Autosomal Dominant Polycystic Kidney	12/24	12/24
PROMENADE, NCT06242327: An Outcome Analysis of Primary Membranous Nephropathy	Not yet recruiting	N/A	500	Europe		Mario Negri Institute for Pharmacological Research	Membranous Nephropathy	05/29	05/29
Canna, Francesco La
No trials found
Piccolo, Giuseppe
No trials found
Carrara, Camillo
No trials found